- Today
- Holidays
- Birthdays
- Reminders
- Cities
- Atlanta
- Austin
- Baltimore
- Berwyn
- Beverly Hills
- Birmingham
- Boston
- Brooklyn
- Buffalo
- Charlotte
- Chicago
- Cincinnati
- Cleveland
- Columbus
- Dallas
- Denver
- Detroit
- Fort Worth
- Houston
- Indianapolis
- Knoxville
- Las Vegas
- Los Angeles
- Louisville
- Madison
- Memphis
- Miami
- Milwaukee
- Minneapolis
- Nashville
- New Orleans
- New York
- Omaha
- Orlando
- Philadelphia
- Phoenix
- Pittsburgh
- Portland
- Raleigh
- Richmond
- Rutherford
- Sacramento
- Salt Lake City
- San Antonio
- San Diego
- San Francisco
- San Jose
- Seattle
- Tampa
- Tucson
- Washington
Ramsey Today
By the People, for the People
Capital Research Global Investors Invests $47.70 Million in ADMA Biologics
The investment firm purchased a new stake in the biotechnology company during the third quarter.
Mar. 13, 2026 at 8:20am
Got story updates? Submit your updates here. ›
Capital Research Global Investors purchased a new stake of 3,253,913 shares in ADMA Biologics Inc (NASDAQ:ADMA), a biotechnology company, during the third quarter. The investment is valued at approximately $47,702,000, making Capital Research Global Investors a 1.36% owner of ADMA Biologics as of its most recent SEC filing.
Why it matters
This investment by a major institutional investor like Capital Research Global Investors signals confidence in ADMA Biologics' business and growth potential. As a biotechnology company focused on plasma-derived biologics, ADMA Biologics' performance is closely watched by the industry and investors.
The details
According to the Form 13F filing with the Securities & Exchange Commission, Capital Research Global Investors purchased the new stake in ADMA Biologics during the third quarter. The 3,253,913 shares acquired are valued at around $47,702,000, giving the investment firm a 1.36% ownership stake in the biotechnology company.
- Capital Research Global Investors purchased the new stake in ADMA Biologics during the third quarter.
The players
Capital Research Global Investors
An investment management firm that provides investment services to individual and institutional investors.
ADMA Biologics Inc
A biopharmaceutical company that focuses on the development, manufacturing and commercialization of specialty plasma-derived biologics for the treatment of primary immunodeficiency and infectious diseases.
The takeaway
This investment by a major institutional investor like Capital Research Global Investors demonstrates confidence in ADMA Biologics' ability to grow its business in the plasma-derived biologics market, which is an important segment of the biotechnology industry.
